Il Dong Pharmaceutical Co - Stock

Il Dong Pharmaceutical Co Revenue 2024

Il Dong Pharmaceutical Co Revenue

660.64 B KRW

Il Dong Pharmaceutical Co Dividend yield

2.62 %

Ticker

249420.KS

ISIN

KR7249420001

In 2024, Il Dong Pharmaceutical Co's sales reached 660.64 B KRW, a 9.97% difference from the 600.76 B KRW sales recorded in the previous year.

The Il Dong Pharmaceutical Co Revenue history

YEARREVENUE (undefined KRW)GROSS MARGIN (%)
2026e765.5827,93
2025e718.1129,78
2024e660.6432,37
2023600.7635,60
2022637.7137,06
2021560.1339,18
2020561.8542,43
2019517.4744,90
2018503.9150,64
2017460.6549,11
2016201.3448,32

Il Dong Pharmaceutical Co Aktienanalyse

What does Il Dong Pharmaceutical Co do?

Il Dong Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Il Dong Pharmaceutical Co's Sales Figures

The sales figures of Il Dong Pharmaceutical Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Il Dong Pharmaceutical Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Il Dong Pharmaceutical Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Il Dong Pharmaceutical Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Il Dong Pharmaceutical Co Stock

How much revenue did Il Dong Pharmaceutical Co generate this year?

Il Dong Pharmaceutical Co has achieved a revenue of 660.64 B KRW this year.

How much was the turnover of the company Il Dong Pharmaceutical Co compared to the previous year?

The revenue of Il Dong Pharmaceutical Co has increased by 9.97% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Il Dong Pharmaceutical Co?

The revenue of Il Dong Pharmaceutical Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Il Dong Pharmaceutical Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Il Dong Pharmaceutical Co so important for investors?

The revenue of Il Dong Pharmaceutical Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Il Dong Pharmaceutical Co pay?

Over the past 12 months, Il Dong Pharmaceutical Co paid a dividend of 362.81 KRW . This corresponds to a dividend yield of about 2.62 %. For the coming 12 months, Il Dong Pharmaceutical Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of Il Dong Pharmaceutical Co?

The current dividend yield of Il Dong Pharmaceutical Co is 2.62 %.

When does Il Dong Pharmaceutical Co pay dividends?

Il Dong Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Il Dong Pharmaceutical Co?

Il Dong Pharmaceutical Co paid dividends every year for the past 3 years.

What is the dividend of Il Dong Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Il Dong Pharmaceutical Co located?

Il Dong Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Il Dong Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Il Dong Pharmaceutical Co from 4/11/2019 amounting to 380.952 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2018.

When did Il Dong Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 4/11/2019.

What was the dividend of Il Dong Pharmaceutical Co in the year 2023?

In the year 2023, Il Dong Pharmaceutical Co distributed 0 KRW as dividends.

In which currency does Il Dong Pharmaceutical Co pay out the dividend?

The dividends of Il Dong Pharmaceutical Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Il Dong Pharmaceutical Co

Our stock analysis for Il Dong Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Il Dong Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.